Literature DB >> 11243382

Development and characterization of T cell leukemia cell lines established from SCL/LMO1 double transgenic mice.

D S Chervinsky1, D H Lam, X F Zhao, M P Melman, P D Aplan.   

Abstract

We have established a panel of nine immortal cell lines from T cell malignancies which arose in mice transgenic for the SCL and LMO1 genes. Cells from the primary malignancies initially grew very slowly in vitro, loosely attached to a stromal layer, before gaining the ability to proliferate independently. Upon gaining the ability to proliferate in the absence of a stromal layer, these cell lines grew rapidly, doubling every 14-23 h, to a very high density, approaching 10(7) cells/ml. Whereas the tumors which arise in SCL/LMO1 double transgenic mice are typically diploid or pseudodiploid, the cell lines were all grossly aneuploid, suggesting the possibility that additional genetic events were selected for in vitro. Given that SCL and LMO1 gene activation are both commonly seen in human patients with T cell acute lymphoblastic leukemia, these cell lines may be a useful in vitro model for the human disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11243382     DOI: 10.1038/sj.leu.2401997

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  8 in total

1.  Derivation of thymic lymphoma T-cell lines from Atm(-/-) and p53(-/-) mice.

Authors:  Rasika Jinadasa; Gabriel Balmus; Lee Gerwitz; Jamie Roden; Robert Weiss; Gerald Duhamel
Journal:  J Vis Exp       Date:  2011-04-03       Impact factor: 1.355

2.  Somatic mutations in murine models of leukemia and lymphoma: Disease specificity and clinical relevance.

Authors:  Liat Goldberg; Sheryl M Gough; Fan Lee; Christine Dang; Robert L Walker; Yuelin J Zhu; Sven Bilke; Marbin Pineda; Masahiro Onozawa; Yang Jo Chung; Paul S Meltzer; Peter D Aplan
Journal:  Genes Chromosomes Cancer       Date:  2017-03-31       Impact factor: 5.006

3.  Notch1 mutations are important for leukemic transformation in murine models of precursor-T leukemia/lymphoma.

Authors:  Ying-Wei Lin; Rebecca A Nichols; John J Letterio; Peter D Aplan
Journal:  Blood       Date:  2005-11-10       Impact factor: 22.113

4.  Mcm2 hypomorph leads to acute leukemia or hematopoietic stem cell failure, dependent on genetic context.

Authors:  Toshihiro Matsukawa; Mianmian Yin; Timour Baslan; Yang Jo Chung; Dengchao Cao; Ryan Bertoli; Yuelin J Zhu; Robert L Walker; Amy Freeland; Erik Knudsen; Scott W Lowe; Paul S Meltzer; Peter D Aplan
Journal:  FASEB J       Date:  2022-09       Impact factor: 5.834

5.  Gene expression profiling of precursor T-cell lymphoblastic leukemia/lymphoma identifies oncogenic pathways that are potential therapeutic targets.

Authors:  Y-W Lin; P D Aplan
Journal:  Leukemia       Date:  2007-04-12       Impact factor: 11.528

6.  NUP98-PHF23 is a chromatin-modifying oncoprotein that causes a wide array of leukemias sensitive to inhibition of PHD histone reader function.

Authors:  Sheryl M Gough; Fan Lee; Fan Yang; Robert L Walker; Yeulin J Zhu; Marbin Pineda; Masahiro Onozawa; Yang Jo Chung; Sven Bilke; Elise K Wagner; John M Denu; Yi Ning; Bowen Xu; Gang Greg Wang; Paul S Meltzer; Peter D Aplan
Journal:  Cancer Discov       Date:  2014-02-17       Impact factor: 39.397

7.  p16INK4A tumor suppressor gene expression and CD3epsilon deficiency but not pre-TCR deficiency inhibit TAL1-linked T-lineage leukemogenesis.

Authors:  Magali Fasseu; Peter D Aplan; Martine Chopin; Nicolas Boissel; Jean-Christophe Bories; Jean Soulier; Harald von Boehmer; François Sigaux; Armelle Regnault
Journal:  Blood       Date:  2007-05-16       Impact factor: 22.113

8.  Generation of a uniform thymic malignant lymphoma model with C57BL/6J p53 gene deficient mice.

Authors:  Susu Liu; Jianjun Lyu; Qianqian Li; Xi Wu; Yanwei Yang; Guitao Huo; Qingfen Zhu; Ming Guo; Yuelei Shen; Sanlong Wang; Changfa Fan
Journal:  J Toxicol Pathol       Date:  2022-09-26       Impact factor: 1.628

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.